Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Laurent Peyrin‐Biroulet(Délégation Centre-Est), Joannie Ruel(Centre Hospitalier Universitaire de Sherbrooke), Mark S. Silverberg(Sinai Health System), Péter L. Lakatos(McGill University), Remo Panaccione(University of Calgary), Suneeta Krishnareddy(Presbyterian Hospital), Stephen B. Hanauer(Northwestern University), Gionata Fiorino(Carlo Forlanini Hospital), Bruce E. Sands(Icahn School of Medicine at Mount Sinai), Robert H. Riddell(Mount Sinai Hospital), Philippe Marteau(Eaton (Taiwan)), Marla C. Dubinsky(Icahn School of Medicine at Mount Sinai), Jaap Stoker(University of Amsterdam), Iris Dotan(Tel Aviv University), William J. Sandborn(University of San Diego), Sarah O’Donnell(Mount Sinai Hospital), Richard B. Gearry(Waitaki Biosciences (New Zealand)), Mark Samaan(New Leaders), Julián Panés(Hospital Clínic de Barcelona), Gert Van Assche(KU Leuven), Benjamin Pariente(New Leaders), Silvio Danese(IRCCS Ospedale San Raffaele), Brian G. Feagan(Western University), David T. Rubin(University of California System), Willem A. Bemelman(Vrije Universiteit Amsterdam), Edward V. Loftus(Mayo Clinic), Geert D’Haens(Amsterdam University Medical Centers), Guillaume Bouguen(Inserm), Shawn Winer(University of Toronto), Simon Travis(University of Oxford), Íngrid Ordás(New Leaders), Corey A. Siegel(Dartmouth–Hitchcock Medical Center), Travis B. Murdoch(Mount Sinai Hospital), Pia Munkholm(Zealand University Hospital), Walter Reinisch(Medical University of Vienna), Robert V. Bryant(Queen Elizabeth Hospital), S Schreiber(New Leaders)
Cited by 1,837
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k